From the Departments of Anesthesiology.
Biostatistics, University of Colorado School of Medicine, Aurora, Colorado.
Anesth Analg. 2020 Aug;131(2):555-563. doi: 10.1213/ANE.0000000000004553.
Postoperative hypoxemia (POH) is common and primarily treated with temporary oxygen supplementation. Because the clinical impact of POH is sometimes presumed as minor, efforts to better understand and minimize it have been limited. Here, we hypothesized that, after adjusting for opioids received perioperatively and other confounders, the frequency of POH events (POH%) reported within the first 3 postoperative days (PODs) is associated with increased postoperative 1-year mortality.
With prior institutional review board (IRB) approval, the Epic Clarity database was queried for all adult inpatient anesthesia encounters performed at our health system (1 academic and 2 community hospitals) from January 1, 2012 to March 31, 2016. Patients with multiple hospitalizations or subsequent surgeries within the same hospitalization were excluded. We classified patients based on the presence (POH) or not (No-POH) of ≥1 documented peripheral saturation of oxyhemoglobin (SpO2) ≤85% event of any duration occurring between the discharge from the postanesthesia care unit (PACU) until POD 3. Demographics, comorbidities, surgery duration, morphine milligram equivalents (OMME) administered perioperatively, respiratory therapies, intensive care unit (ICU) admission, and hospital length of stay (LOS) were also collected. Logistic regression was used to characterize the association between POH and 1-year postoperative mortality after adjusting for perioperatively administered opioids and other confounding factors.
A total of 43,011 patients met study criteria. At least 1 POH event was reported in 10,727 (24.9%) patients. Of these, 7179 (66.9%) had ≥1 hypoxemic event on POD 1, 5340 (49.8%) on POD 2, and 3455 (32.3%) on POD 3. Patients with ≥1 POH event, compared to No-POH patients, were older, had more respiratory and other comorbidities, underwent longer surgeries, received greater opioid doses on the day of surgery and POD 1, and received more continuous pulse oximetry monitoring. POH patients required more frequent postoperative oxygen therapy, noninvasive ventilation (NIV), intubation, and ICU admission. One-year postoperative mortality occurred in 4.4% of patients with ≥1 POH and 3.0% of No-POH patients (P < .001). After adjusting for confounding factors, for every 10% increase in the frequency of SpO2 ≤85% readings, the odds of postoperative 1-year mortality were 1.20 (95% confidence interval [CI], 1.11-1.29; P < .001). Perioperative opioids were not independently associated with increased 1-year mortality.
After adjusting for perioperative opioids and other confounders, moderate/severe POH within the first 3 PODs was independently associated with increased 1-year postoperative mortality. Increased efforts should be directed to understand if efforts to detect and reduce POH lead to improved patient outcomes.
术后低氧血症(POH)较为常见,主要通过临时吸氧进行治疗。由于 POH 的临床影响被认为是轻微的,因此,人们对其进行深入了解并加以最小化的努力有限。在此,我们假设,在调整围手术期接受的阿片类药物和其他混杂因素后,报告的前 3 个术后日(POD)内的 POH 事件(POH%)的频率与术后 1 年死亡率增加相关。
在获得机构审查委员会(IRB)的事先批准后,我们对我院健康系统(1 家学术医院和 2 家社区医院)于 2012 年 1 月 1 日至 2016 年 3 月 31 日期间所有成人住院麻醉手术的 Epic Clarity 数据库进行了查询。排除多次住院或在同一住院期间进行后续手术的患者。我们根据在离开麻醉后护理单位(PACU)至 POD 3 之间是否存在任何持续时间的至少 1 次记录的外周血氧饱和度(SpO2)≤85%的≥1 次文档化的低氧血症事件(POH)将患者分为存在(POH)或不存在(No-POH)。收集患者的人口统计学数据、合并症、手术持续时间、围手术期给予的吗啡毫克当量(OMME)、呼吸治疗、重症监护病房(ICU)入院和住院时间(LOS)。使用逻辑回归来描述 POH 与 1 年后术后死亡率之间的关联,在调整围手术期给予的阿片类药物和其他混杂因素后。
共有 43011 名患者符合研究标准。在 10727 名(24.9%)患者中报告了至少 1 次 POH 事件。其中,7179 名(66.9%)在 POD 1 有≥1 次低氧血症事件,5340 名(49.8%)在 POD 2 有,3455 名(32.3%)在 POD 3 有。与 No-POH 患者相比,发生≥1 次 POH 事件的患者年龄更大,有更多的呼吸和其他合并症,手术时间更长,手术当天和 POD 1 给予的阿片类药物剂量更大,接受了更多的连续脉搏血氧监测。POH 患者需要更频繁地接受术后氧疗、无创通气(NIV)、插管和 ICU 入院。在≥1 次 POH 患者中,有 4.4%的患者发生术后 1 年死亡率,而 No-POH 患者中为 3.0%(P<.001)。在调整混杂因素后,SpO2≤85%读数每增加 10%,术后 1 年死亡率的比值比为 1.20(95%置信区间[CI],1.11-1.29;P<.001)。围手术期阿片类药物与增加的 1 年死亡率无关。
在调整围手术期阿片类药物和其他混杂因素后,前 3 个 POD 内的中度/重度 POH 与增加的术后 1 年死亡率独立相关。应加大力度了解是否努力发现和减少 POH 会改善患者的预后。